Clinical Trials Logo
  1. Home
  2. Cerebral Hemorrhage
  3. NCT06242938

Early Intensive Antihypertensive Treatment in High-Risk Population of intraCerebral Hemorrhage ExpanSion Predicted by Artificial Intelligence — ARCHES  

Cerebral Hemorrhage Clinical Trial

Official title:
Early Intensive Antihypertensive Treatment in High-risk Population of Intracerebral Hemorrhage Expansion Predicted by Artificial Intelligence

Clinical Trial Summary

The goal of this clinical trial is to clarify the efficacy, safety and feasibility of early intensive antihypertensive treantment in intracerebral hemorrhage (ICH) patients at high risk of hematoma expansion based on artificial intelligence prediction. The main question it aims to answer are: - Can ICH patients at high risk of hematoma expansion based on artificial intelligence prediction benefit from early intensive antihypertensive treatment? - Is early intensive antihypertensive treatment safe to patients at high risk of hematoma expansion based on artificial intelligence prediction. Participants will accept intensive antihypertensive treatment (target systolic blood pressure: 130-140mmHg) at early stage (within 1 hour after randomization) of cerebral hemorrhage and maitain the target blood pressure for 7 days. Researchers will compare standard treatment group (target systolic blood pressure 140-180mmHg after randomization) to see if intensive antihypertensive treatment can improve the outcome of patients with ICH.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06242938
Study type Interventional
Source Beijing Tiantan Hospital
Contact Na Li, MD, PhD
Phone +8613701086873
Email selina1808@163.com
Status Not yet recruiting
Phase N/A
Start date February 15, 2024
Completion date January 31, 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT04741334 - Mild Head Injury, Antiplatelets, and Anticoagulants
Completed NCT02565693 - Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation Phase 2
Recruiting NCT01866384 - Targeted Temperature Management After Intracerebral Hemorrhage Phase 2
Completed NCT00029315 - Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage Phase 2
Active, not recruiting NCT06230419 - Retrospective Study on the Direction of Artificial Intelligence in Identifying Cranial Trauma CT Imaging
Not yet recruiting NCT04144868 - Safety and Efficacy of NBO in Acute Intracerebral Hemorrhage N/A
Recruiting NCT05118997 - Active Removal of IntraCerebral Hematoma Via Active Irrigation N/A
Active, not recruiting NCT02258919 - Decompressive Hemicraniectomy in Intracerebral Hemorrhage N/A
Completed NCT01472224 - Volume Measurement and Progression Surveillance of Intracerebral Haemorrhage Using Transcranial Ultrasound N/A
Recruiting NCT06078020 - PLatform Study for INTracerebral Haemorrhage (PLINTH): Community-based Feasibility Study
Completed NCT01467206 - Life After STroke - the LAST Study N/A
Completed NCT00226096 - Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage N/A
Recruiting NCT03815149 - Safety and Clinical Effectiveness of Pipeline™ Shield Devices for Intracranial Aneurysms
Completed NCT00579943 - Regulation of Cerebral Blood Flow in Very Low Birth Weight Infants N/A
Recruiting NCT05424614 - Study on the Prognostic Prediction Model of Patients With Acute Intracerebral Hemorrhage by Artificial Intelligence
Completed NCT03000283 - Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability Study Phase 1
Active, not recruiting NCT02283879 - Human Umbilical Cord Mesenchymal Stem Cell in Cerebral Hemorrhage Sequela Phase 1
Active, not recruiting NCT02240394 - TCD Detection of Ophthalmic Artery Blood Flow Velocity Prediction Feasibility Study of Intracranial Pressure N/A
Completed NCT01858675 - Biomarkers Correlation With Volemia N/A
Completed NCT00363662 - Diagnostic Utility of MRI in Intracerebral Hemorrhage